Introduction
Periodic limb movements of sleep (PLMS) are sleep-related phenomena characterized by periodic episodes of repetitive and highly stereotyped limb movements, which most often occur in the lower extremities. PLMS can be associated with brief arousals or full awakenings from sleep [1] , and nearly all PLMS are accompanied by an autonomic reaction [2] .
PLMS are frequently seen in restless legs syndrome (RLS), and excessive PLMS represents a supportive criterion for the diagnosis of RLS [3] . PLMS have been documented in other sleep disorders, such as sleep disordered breathing [4] , narcolepsy [5] and REM sleep behavior disorder [6] , as well as in several medical conditions, like renal failure [7] , essential hypertension [8] , Parkinson's disease [9] , or associated with medication intake (in particular antidepressants and neuroleptics) [10] . Excessive PLMS have also been proposed as an independent cause of sleep disturbance. Periodic limb movement disorder (PLMD) is defined as the presence of >15 PLMS per hour and a complaint of insomnia and/or excessive daytime sleepiness with no other explanation for these symptoms [1] . In other cases, it is the bed partner who complains of being disturbed by these movements [1] . Furthermore, PLMS may be present without any complaint of disturbed sleep or daytime sleepiness, especially in elderly subjects.
Although the clinical relevance of PLMS is not completely established, evidence is emerging that, in addition to disturbing sleep, PLMS could be associated with an increased risk of cardiovascular disease by increasing sympathetic nervous system activity [11] , even though a conclusive association and causality remains to be demonstrated [12] . 
Subjects
The HypnoLaus Sleep Cohort study included subjects of the population-based CoLaus/PsyCoLaus Cohort study described previously [20] [21] [22] . Briefly, the CoLaus/PsychoLaus study included a random sample of 6733 subjects (range age: 35-75 years) selected from the residents of Lausanne city (Switzerland) between 2003 and 2006. The distribution of age groups, gender, and zip codes of participants were similar to the source population [20] . During the first follow up of the cohort, five years after the initial phase, all subjects who participated underwent a new physical (n=5064) and psychiatric (n=4000) examination. HypnoLaus evaluated the subjective and objective sleep characteristics in a random subset of this population. Sleep-related complaints and habits were investigated using several questionnaires among which the International Restless Legs Syndrome Study Group (IRLSSG) criteria for the diagnosis of RLS [23] . All subjects had a complete PSG at home. In the morning following the polysomnographic recording participants completed a questionnaire providing information about the quality of their sleep in the previous night, the amount of alcohol consumed 4 hours before going to bed, and their current medication.
CoLaus/PsyCoLaus and HypnoLaus were approved by the Ethics Committee of the University of Lausanne and a written informed consent was obtained from all participants. six electroencephalography, two electrooculography, three surface electromyography (one submental, two for right and left anterior tibialis muscles), one for electrocardiogram, nasal pressure, thoracic and abdominal belts, body position, oxygen saturation and pulse rate. Surface leg electrodes were placed longitudinally and symmetrically around the middle of the muscle so that they were 2 to 3 cm apart or 1/3 of the length of the anterior tibialis muscle, whichever was shorter. Separate channels for both legs were used.
All PSG recordings were visually scored by two trained sleep technicians (DA and NT) using . Using a case-cohort approach ferritin was measured in a subsample (n=619) randomly selected by stratified sampling from the HypnoLaus population, according to gender and 10-years age interval group. Multiple imputation was used to make inference to the whole cohort [31] .
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Genotyping
We used CoLaus/PsyCoLaus genome-wide genotype data and imputation, that has been described elsewhere [32] . summarized as number of subjects and percentages. We compared subjects with PLMSI ≤15/h and subjects with PLMSI>15/h using the χ2 test, Student's t test, or Wilcoxon's rank-sum test.
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We used Cohen's d to calculate the effect size of the differences between participants who underwent polysomnography and those who did not. We performed multiple imputation for the analysis of the case-cohort data [31] using the mice package [35] in order to impute ferritin levels.
Then we used logistic regression models to assess the association between demographic, clinical and genetic variables and a PLMSI>15/h.
Logistic regression was applied for 2,557,249 SNPs genome-wide, correcting for age and gender.
Effect size, standard error and P-value were calculated for each SNP. We also applied linear regression for inverse normal quantile transformed raw PLMSI values using the same covariates.
The assessment of PLMS in the presence of sleep disordered breathing (SDB) is challenging by the fact that leg movements may be triggered by the respiratory events and are not part of a PLMS sequence. For this reason we also analyzed PLMS determinants in subjects without significant SDB, with an AHI cut-off value of 15/h[1].
Statistical significance was considered for a two-sided test p-value <0.05.
Results

Description of the Sample
Of 3043 consecutive subjects from the first follow-up of the population-based
CoLaus/PsyCoLaus cohort study, 2168 (71.1%) agreed to have a PSG at home. Technical problems resulting in insufficient data for PSG scoring were encountered in 60 cases (2.8%); 54 
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subjects accepted to repeat the PSG and 6 subjects declined, resulting in 2162 participants (51.2% women, mean age 58.4±11.1 years) included in the final analysis (Figure 1) . Compared with the whole CoLaus/PsyCoLaus cohort, subjects who underwent PSG were similar in terms of age, sex, BMI, and ethnic origin, and they were representative of Lausanne's general population [20] .
General Characteristics
For the whole population, the median (P05-P95) PLMSI was 2 (0-64)/h, the upper 5% centile 
Prevalence of PLMSI>15/h
The overall prevalence of PLMSI>15/h was 28.6% (31.3% in men and 26.0% in women) in our middle to older aged general population sample. In the group with PLMSI>15/h, PLMS were present during all stages of NREM sleep, persisting during stage 3, but more rarely during REM sleep (p<0.001), and 14% of them were associated with an EEG-arousal.
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Determinants of PLMSI>15/h
Compared to subjects with PLMSI≤15/h, subjects with a PLMSI>15/h were significantly older, more frequently men, had a higher BMI and a higher prevalence of overweight and obesity.
Subjects with PLMSI>15/h also had an increased prevalence of hypertension, diabetes and a higher rate of postmenopausal women. For women, there were no significant differences between groups concerning the number of pregnancies ( Table 1) .
Regarding drug treatment, subjects with a PLMSI>15/h reported more frequently taking hypnotics and betablockers, while borderline associations were found for antidepressants, antihistaminics and neuroleptics ( Table 1) . On the other hand, no differences were found for consumption of caffeine, alcohol or tobacco ( Table 1) .
Subjects with a PLMSI>15/h reported more RLS-related symptoms (Table 1) . However, three quarters of them did not complain about RLS. When stratifying PLMS+ subjects according to the presence or absence of RLS symptoms, RLS+ was associated with a higher proportion of women, psychotropic drug (neuroleptics, hypnotics, antidepressants and benzodiazepine) use and a lower AHI (Supplementary table 1) .
Subjects with a PLMSI>15/h had a higher AHI ( Table 2) . A weak correlation was found between the PLMSI and the AHI (ρ=0.101, p<0.05), but this association disappeared when adjusting for age (p=0.575).
Concerning iron-related measurements, subjects with PLMSI >15/h had a mildly increased RDW, while no significant differences were found between groups regarding hemoglobin or ferritin levels, or regarding the percentage of subjects with ferritin <100 ng/mL ( Table 2) .
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Although the percentage of subjects with serum ferritin <50 ng/mL tended to be higher in subjects with PLMSI>15/h, this difference was not statistically significant (p=0.155). No significant correlation was noted between the PLMSI and ferritin levels (p=0.063). Otherwise, a PLMSI>15/h was associated with lower glomerular filtration rate and higher percentage of CKD ( Table 2) .
GWAS analysis revealed BTB domain-containing 9 (BTBD9) gene as the region showing genome-wide significant association, and confirmed strong association of rs3923809 SNP with PLMSI [18] . The association between the A allele of rs3923809 and PLMSI>15/h was genomewide significant at p=9. 
Interestingly, we found another SNP (not in LD with rs197519) with stronger association in PTPRD (rs10977209 (P = 7.27e-04)) surviving 5% FDR.
Multivariate analysis of the determinants of PLMSI>15/h
As a next step, we examined the association of a PLMSI>15/h and predetermined variables from the univariate analysis and other previously reported possible determinants, using multiple imputation and a multiple variable logistic regression analysis, in order to determine independent predictors.
The factors significantly and independently associated with a PLMSI>15/h were: age (OR (95% Table 3 ). The strongest genetic association was found for the allele A of rs3923809 of the BTBD9 gene, with a risk ratio for homozygous (AA) compared to homorozygous (GG) carriers estimated at 3.52 (95% CI 2.12-5.86, p<0.001). The AHI showed a negative association (OR: 0.88 (0.77-0.99), p<0.042). Conversely, no significant independent associations were found for BMI, hypertension, diabetes, alcohol, caffeine or tobacco consumption, or for the ferritin levels ( Table 3) .
Restricting the analysis to subjects without significant SDB (AHI <15/h) yielded similar results, with the additional findings that BMI became independently associated with the presence of PMLS >15/h, whereas allele distribution of the rs2300478 SNP was no longer significantly associated (Supplementary table 3) .
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Discussion
To the best of our knowledge, the HypnoLaus Sleep Cohort study is the largest study assessing the prevalence and determinants of PLMS in a population-based sample. We found a high prevalence of PLMS in the general population: 28.6% of our sample had a PLMSI>15/h (31.3%
of men and 26.0% of women). When compared to subjects with a PLMSI≤15/h, subjects with a PLMSI>15/h were older, with a higher percentage of men and postmenopausal women and a higher BMI. A higher percentage of subjects had RLS, diabetes, hypertension and more of them were taking beta-blockers and antidepressants. Their mean glomerular filtration rate was lower, but the mean ferritin level was similar in both groups. We also found significant associations with allele distribution of SNPs within BTBD9 (rs3923809), TOX3 (rs3104788) and MEIS1
(rs2300478) genes. In the multivariate analysis, age, male gender, antidepressant intake, RLS and alleles of rs3923809, rs3104788 and rs2300478 were independently associated with a PLMSI higher than 15/h.
Prevalence of PLMSI>15/h
In our study, analyzing data from 2162 subjects representative of the adult general population of Lausanne, we found a prevalence of PLMSI >15/h of 28.6%. Scofield et al. reported a prevalence of 7.6% in a community-based sample of 592 participants drawn from the general population of Detroit Tri-County using standardized PSG criteria [16] . One possible explanation 
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for this difference is the racial/ethnic distribution in the Scofield's study, with a large African American population, in which the prevalence of PLMS was found to be lower, whereas subjects participating in our study were almost exclusively of European origin. In addition, participants in their study were younger. Finally only an anterior tibialis EMG was used to record PLMS (instead of two separate channels for both legs as in our study), and leg movements were considered when their duration was between 0.5 to 5 sec (instead of between 0.5 to 10 sec as proposed in current scoring criteria[1, 24, 27]). These two technical factors could have contributed to an undervaluation of the presence of PLMS in Scofield's study. The estimate of the prevalence we found is closer to the 33% reported by Moore et al. [17] . In this study authors analyzed PSG data from 1090 participants on the Wisconsin Sleep Cohort, an epidemiological prospective study from the general population that included an enriched selection of people at risk for SDB. In this study a single-leg EMG channel was processed, and an automatic detector allowed recognition of PLM using a previously validated algorithm and slightly modified AASM scoring criteria. Recently, Winkelman et al. using 1993 AASM scoring criteria reported a much higher prevalence of PLMI ≥15 (61%), in participants of the Osteoporotic Fractures in Men Study probably due to the fact that they analyzed data exclusively from community-dwelling men 65 years or older [19] .
Determinants of PLMSI>15/h
As previously described, we found in our study as association between increasing age and PLMS prevalence [16] . PLMS rarely occurs in children and adolescents without associated medical conditions [36] , whereas in the elderly, PLMS are frequently observed, even in subjects without any sleep disturbance [37, 38] .
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In our study, male gender was associated with a higher prevalence of PLMS. Ohayon et al.
reported a higher prevalence in women, but that study was based only on telephone interviews without PSG recordings to confirm the presence of PLMS [15] . Studies using objective methods to determine PLMS (either PSG [16, 17] or actigraphy [39] ) also found a higher prevalence in males.
The occurrence of PLMS has been described in association with the intake of several medications, in particular with drugs impairing dopaminergic transmission and serotoninergic agents. The low frequency use of certain medications in our population, as neuroleptics, prevents from drawing definitive conclusions concerning a possible association with these specific drugs.
Yet, we could show that the intake of antidepressants was independently associated with a PLMSI>15/h. Yang et al., analyzed data from 274 patients treated with antidepressants and found also a significant increase of PLMS during treatment, in particular in those treated with selective serotonin reuptake inhibitors and with venlafaxine [10] . Most other antidepressants can also induce or increase PLMS [40] [41] [42] , with the exception of bupropion that seems to reduce them [10, 43] .
Subjects with PLMS fulfilled more frequently the four cardinal diagnostic features of RLS[23].
This association between RLS and PLMS is well established and the presence of excessive PLMS supports the diagnosis of RLS [3] . This suggests RLS and PLMS may share, to some extent, the same pathophysiological origin. However, it must be stressed that RLS could be present without significant PLMS, and that as many as three quarters of subjects with a PLMSI >15/h did not complaint of RLS. In subjects with PLSMS>15/h, RLS symptoms were more frequent in women and were associated with the intake of psychotropic drugs and with lower 
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AHI. It is thus still unclear if RLS with and without PLMS correspond to different
phenotypes [44] .
In our study, we found a highly significant association between PLMSI and rs3923809, a common A/G single-nucleotide variation in an intron of BTBD9 gene on chromosome 6, pointing to a major genetic contribution to PLMS. The PLMS risk ratio for homozygous carriers (AA) to heterozygous carriers (AG) was estimated at 3.52, and the PLMI was correlated with the presence of allele A, homozygotes having almost threefold increase in leg movements per hour of sleep compared to non A carriers. Our data confirm the findings of Stefansson et al., who first described the association between rs3923809 and PLMS in subjects with RLS [18] . We also examined whether the genotype of this SNP modifies the association of clinically important risk factors (obesity, hypertension, diabetes, dyslipidemia), but no statistically significant interaction was observed. Two recent studies examined the association between PLM and single-nucleotide polymorphisms known to increase risk of RLS [17, 19] . We have also examined other candidate 
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with early-onset symptoms [45] . If a significant correlation has been shown between serum ferritin levels and RLS severity, no clear relationship between declining iron status and PLMS severity have been demonstrate [46] .
Strengths and Limitations
The major strengths of our study is its population-based design, the large sample size, the availability of detailed information on a large number of demographic, clinical and genetic variables and the use of PSG to determine the presence of PLMS and sleep co-morbidities.
Nevertheless, we have to acknowledge potential limitations. First, our results are based on a single PSG, and an individual inter-night variability has been demonstrated in PLMS frequency [47] . The assessment of PLMS was performed using current scoring criteria of leg movements proposed by the WASM. The use of other scoring criteria, as those established by the AASM, could have led to different results in terms of frequency and prevalence of PLMS.
Although these two major international scoring guidelines differ in their definition of respiratory related leg movements (LMs) both specifically exclude LMs occurring at the end (± 0.5 s) of respiratory events from the scoring of PLMS. It is however often difficult to differentiate movements supposed to be secondary to the arousal at the end of respiratory events to PLMS occurring independently and it has been shown that respiratory related LMs can occur in a time interval longer than the 0.5 sec proposed by the current criteria [48] . It is therefore possible that some of the LMs that we have considered as PLMS were actually respiratory related. However, in the multivariate analysis, the AHI showed a negative association with the PLMSI, and when a 
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subgroup with an AHI <15/h was analyzed we found the same determinants of PLMSI >15/h as in the whole population. We evaluated iron status with the ferritin levels (that reflects the storage iron compartment). We cannot exclude that other measures of iron, such as the serum transferrin receptor (that reflects the functional iron compartment) or a combination of indices could have given a clearer picture of functional iron status [49] . Finally, we included in our study subjects aged 40-85 years old only, almost exclusively of European origin. Thus, generalization of findings to younger people or to people from other ethnic backgrounds is limited.
Conclusions
PLMS are highly prevalent in the general population. Age, male gender, antidepressant intake, RLS and alleles rs3923809 of the BTBD9, rs3104788 of the TOX3 and rs2300478 of the MEIS1 genes are independent predictors of a PLMSI >15/h. Further studies are needed to evaluate the clinical impact of PLMS.
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